Company intelligence / Profile preview
Sinopharm Group Zhijun
- Ownership
- Private
- Employees
- ~2000
- Development stage
- Other
Overview
Sinopharm Zhijun is a leading pharmaceutical subsidiary of Sinopharm Group, specializing in the research, development, and large-scale manufacturing of anti-infective medications, particularly cephalosporin antibiotics. Based in Shenzhen, China, the company operates multiple GMP-certified facilities and is recognized as one of the country's largest exporters of cephalosporin products to international markets. Its extensive portfolio includes a wide range of oral and injectable antibiotics, as well as treatments for respiratory and cardiovascular conditions. Sinopharm Zhijun is distinguished by its commitment to global quality standards, having secured EU-GMP certification and WHO prequalification for several of its core products. As a key industrial unit within the Sinopharm ecosystem, the company plays a vital role in the global supply chain for essential anti-infective therapies.
- Therapeutic areas
- Infectious DiseasesPulmonology
- Modalities
- Small molecule
- Industry
- Biotech
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on Sinopharm Group Zhijun.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sinopharm Group Zhijun.